HDAC/JAK/BRD4-IN-1

HDAC/JAK/BRD4-IN-1 is a multi-target inhibitor with potent activity against HDAC, JAK, and BRD4 proteins. It demonstrates robust in vitro effects, including the suppression of proliferation and induction of apoptosis in aggressive cancer cell lines like MDA-MB-231, and has shown promising in vivo anticancer efficacy in research models.